Cancer and Chemoprevention: An Overview

Dr. Summya Rashid did her PhD from Department of Medical Elementology and Toxicology At Jamia Hamdard University, New Delhi, India and currently she is working as a research associate at the same place. Dr. Rashid has primarily worked on renal cell carcinoma and its various aspects. She possesses more than 5 years of research experience in the field of cancer biology and has contributed in 23 publications with h-index of 7. Dr. Rashid has attended various national and international conferences and workshops. In 2015, she was invited as honorary speaker at the International Conference on Antimicrobial Agents and Chemotherapy" at Valencia, Spain. In her short scientific career she has received various awards and fellowships. She is also the recipient of prestigious “Meritorious Research Fellowship” by University Grants Commission-Basic Science Research (UGC-BSR) at Molecular Carcinogenesis & Chemoprevention laboratory, Hamdard University, India in April, 2011.

Introduction.- Hallmarks of Cancer.- Classification of Cancer.- Factors Influencing Cancer Development.- Carcinogenesis.- Molecular Mechanism of Carcinogenesis.- Oxidative Stress Induced Carcinogenesis.- Major Mediators Linking Inflammation and Cancer.-  Apoptosis.- Chemoprevention.- Classification of Chemopreventive Agents.- Preclinical Development of Chemo Preventive Agents for Chemoprevention.- Modulation of Wnt/β-Catenin Signaling by Chemo Prevention.- Modulation of Akt/mTOR Pathway Signaling by Chemo Prevention.- Novel Chemopreventive Agents.- Chemoprevention by Resveratrol.- Chemoprevention by Genistein.- Chemoprevention by Apigenin.- Chemoprevention by Curcumin.- Chemoprevention by Fisetin.- Chemoprevention by Epigallocatechin-3-gallate (EGCG).- Chemoprevention by Graviola.- Cancer Chemoprevention: Hurdles and Future Prospects and Considerations.- Clinical Trials of Chemoprevention.- Future of Chemoprevention.